Skip to content
TrialScanner

NCT03217825

Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan

Phase 2CompletedWINTLead

Registry record

Lead sponsor
Windtree Therapeutics
Conditions
Hypertension
Primary completion
Feb 8, 2018Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03217825 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03217825: Antihypertensive Effect of... | TrialScanner